<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>THE INFLUENCE OF TGF-β IN TUMOR DEVELOPMENT</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Abdullayeva</mods:namePart><mods:namePart type="family">Dilafruz Shavkatovna</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Matkarimova</mods:namePart><mods:namePart type="family">Dilfuza Saburovna</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Botirova</mods:namePart><mods:namePart type="family">Khurshida Makhmadaliyevna</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>The main biological properties of TGF-β are involved in cell proliferation, differentiation, control of cell proliferation and innervation during embryonic development, bone tissue formation, hematopoiesis, regenerative and immunological tolerance formation. In tumors, TGF-β can act as a proto-oncogene or tumor suppressor, depending on the type and stage of the tumor cell. Controlling the level of TGF-β in the blood can prevent the progression of oncological and autoimmune pathologies</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-04-15</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Conferences</mods:publisher></mods:originInfo><mods:genre>Article</mods:genre></mods:mods>